Naz Rahman

Stock Analyst at Maxim Group

(0.67)
# 2469
Out of 5,383 analysts
51
Total ratings
Success rate
Average return
23 Stocks
Name Action PT Current % Upside Ratings Updated
GLMD Galmed Pharmaceutica...
Downgrades: Hold
n/a
n/a n/a 1 Apr 4, 2025
NVCT Nuvectis Pharma
Initiates Coverage On: Buy
17
7.73 119.92% 1 Apr 2, 2025
SLXN Silexion Therapeutic...
Maintains: Buy
9 5
0.81 517.28% 2 Mar 20, 2025
SCPH scPharmaceuticals
Maintains: Buy
20 12
3.98 201.51% 3 Mar 20, 2025
VKTX Viking Therapeutics
Maintains: Buy
120 70
28.17 148.49% 5 Feb 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 2 Dec 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
n/a
n/a n/a 4 Nov 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
23 8
0.71 1026.76% 7 Nov 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 2 Oct 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 4 Oct 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
3
0.65 361.54% 1 Jul 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 2 Jun 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 3 Mar 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
525 140
9.23 1416.79% 2 Mar 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 1 Jan 31, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
100
n/a n/a 1 Dec 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 3 Nov 17, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
5
2.07 141.55% 1 Aug 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 2 Aug 22, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 1 May 9, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
6
2.44 145.9% 1 Feb 25, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 1 Dec 7, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
27
n/a n/a 1 Mar 31, 2021